Effect of Vitamin D Treatment in Primary Hyperparathyroidism
Effect of Vitamin D Treatment in Primary Hyperparathyroidism
The primary aim of the study is to assess whether 6-months of vitamin D supplements can
 decrease PTH compared with placebo treatment in primary hyperparathyroidism.
The study investigates effects and safety of six months of vitamin D supplementation before
 and after surgery in primary hyperparathyroidism. Effects are assessed as changes in calcium
 homeostasis, bone metabolism, quality of life, and muscle strength and function.
Inclusion Criteria:

 -  P-Ca-ion > 1,30 mmol/l

 -  P-PTH > 5 pmol/l

 -  P-OH25-vitamin D < 80 nmol/l

 Exclusion Criteria:

 -  P-creatinin > 120 mumol/l

 -  usage of Etalpha, Mimpara

 -  Cancer

 -  Sarcoidosis

 -  malabsorption

 -  pancreatitis

 -  alcohol abuse

 -  pregnancy